About
Rui Tostoes is a cell therapy and bioprocessing operator currently serving as Chief Technology Officer at ImmuneBridge. ImmuneBridge describes him as an accomplished scientist with prior work at MilliporeSigma and FloDesign Sonics, focused on product and people development in cell therapy and bioprocessing. Earlier public records from the MIT Portugal Program show him pursuing a Bioengineering Systems PhD with a high-throughput screening and microbioreactors research focus.
Areas of interest
biotechcell therapygene therapybioprocessingcell therapy manufacturingallogeneic immune therapiesstem cellsmicrobioreactorshigh-throughput screening